Suchergebnisse - "Aoki, Daisuke"

PubPharm (18)

1

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer : a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2023

von Mizuno, M. | Ito, K. | Nakai, H. | +18

2

Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer

enthalten in: Gynecologic oncology | 2022

von Rubinstein, M. | Shen, S. | Monk, B. | +5

3

Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients

enthalten in: International journal of clinical oncology | 2022

von Iwasa-Inoue, N. | Nomura, H. | Kataoka, F. | +9

4

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma : results from a randomized phase III study in JGOG3017/GCIG

enthalten in: Journal of gynecologic oncology | 2020

von Kondo, E. | Tabata, T. | Suzuki, N. | +12

5

Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial

enthalten in: Gynecologic oncology | 2019

von Nomura, H. | Aoki, D. | Susumu, N. | +10

6

Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2019

von Nomura, H. | Aoki, D. | Michimae, H. | +15

CommentIn: Transl Cancer Res. 2019 Oct;8(6):2220-2222. - PMID 35116974

7

Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer

enthalten in: Japanese journal of clinical oncology | 2017

von Yoshihama, T. | Nomura, H. | Iwasa, N. | +9

8

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma : JGOG3017/GCIG Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Sugiyama, T. | Okamoto, A. | Enomoto, T. | +21

9

A Phase II clinical trial of pegylated liposomal doxorubicin and carboplatin in Japanese patients with platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancer

enthalten in: Japanese journal of clinical oncology | 2015

von Nakanishi, T. | Aoki, D. | Watanabe, Y. | +4

10

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016) : a randomised, controlled, open-label trial

enthalten in: The Lancet. Oncology | 2013

von Katsumata, N. | Yasuda, M. | Isonishi, S. | +10

CommentIn: Lancet Oncol. 2013 Sep;14(10):920-1. - PMID 23993374